Ali J. Satvat Insider Trading $EIDX Eidos Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Ali J. Satvat.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Ali J. Satvat. Ali J. Satvat is Director in Coherus BioSciences, Inc. ($CHRS) and Director in Eidos Therapeutics, Inc. ($EIDX) and Director in BridgeBio Pharma, Inc. ($BBIO).

Ali J. Satvat in Eidos Therapeutics, Inc.

Trading Symbol: EIDX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali J. Satvat: Director
Holdings: 24,575,501 shares
Latest Transaction: Jan 28 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 5x
Sell: 1x
Shares Bought: 22,694,971
Shares Sold: 211,762
Share Difference: +22,483,209
Value Difference: -$94,788,416

Latest Insider Trading Transactions of Ali J. Satvat in Eidos Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BBIO, CHRS, EIDX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 28 2021EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseD20.3443,056875,7590
Jan 28 2021EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseD30.8721,528664,5690
Jan 28 2021EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseD48.5121,5281,044,3230
May 29 2020EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseA48.5121,5281,044,32321,528
Jul 08 2019EIDXEidos Therapeutics ...Satvat Ali J.DirectorBuyP29.90882,35326,382,79624,575,50123.7 M to 24.6 M (+3.72 %)
Jul 08 2019EIDXEidos Therapeutics ...Satvat Ali J.DirectorBuyP29.90882,35326,382,79624,575,50123.7 M to 24.6 M (+3.72 %)
Jun 13 2019EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseA30.8721,528664,56921,528
Jun 13 2019EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseA30.8721,528664,56921,528
May 29 2019EIDXEidos Therapeutics ...Satvat Ali J.DirectorBuyP25.931,103,84828,622,77923,693,14822.6 M to 23.7 M (+4.89 %)
Jul 03 2018EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseA20.3443,056875,75943,056
Jun 22 2018EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseC0.0012,832,12300
Jun 22 2018EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseC0.002,909,02900
Jun 22 2018EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseX0.00332,26202,909,029
Jun 22 2018EIDXEidos Therapeutics ...Satvat Ali J.DirectorOption ExerciseX10.83332,2623,599,9920
Jun 22 2018EIDXEidos Therapeutics ...Satvat Ali J.DirectorBuyP17.001,000,00017,000,00019,614,65518.6 M to 19.6 M (+5.37 %)
Jun 22 2018EIDXEidos Therapeutics ...Satvat Ali J.DirectorPayment of ExerciseF17.00211,7623,599,95418,614,65518.8 M to 18.6 M (-1.12 %)
Jun 22 2018EIDXEidos Therapeutics ...Satvat Ali J.DirectorBuyC0.0018,826,417018,826,4170 to 18.8 M

Page:   1